By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quidel announced on Friday that the US Food and Drug Administration has cleared for marketing two of its molecular tests, one for human metapneumovirus and the other for influenza A and B, making them the San Diego company's first FDA-cleared MDx tests.

The Quidel Molecular hMPV Assay is the first molecular test from the company to receive FDA 510(k) clearance, it said, adding it was launched in Europe after getting CE marked in September 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.